Search
for

    Sort by

    Research 21

    1. Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts Clinics in Dermatology · 2011 · 19 citations
    2. Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team International Journal of Clinical Oncology · 2026
    3. Dermatologic Side Effects of Systemic Targeted Anticancer Therapy Springer eBooks · 2018
    4. Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy Dermatology Review · 2016 · 4 citations
    5. Dermatologic Adverse Events from Cancer Treatments Springer eBooks · 2018 · 2 citations
    6. Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer Journal of the American Academy of Dermatology · 2014 · 88 citations
    7. Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review) Oncology Reports · 2012 · 46 citations
    8. Advances in the Management of Cutaneous Toxicities of Targeted Therapies Seminars in Oncology · 2012 · 42 citations
    9. Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology Clinical & Translational Oncology · 2018 · 26 citations
    10. Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma Archives of Medical Science · 2017 · 16 citations
    11. Drug eruptions in dermatology Expert Review of Dermatology · 2011 · 11 citations
    12. The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma Current Dermatology Reports · 2013 · 6 citations
    13. Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review International Journal of Medical Sciences · 2025 · 4 citations
    14. Chemotherapy and Cutaneous Drug Reactions Springer eBooks · 2015 · 1 citations
    15. Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy Journal of the American Academy of Dermatology · 2018 · 32 citations
    16. Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies Biomedicines · 2025
    17. Understanding, recognizing, and managing toxicities of targeted anticancer therapies Ca · 2013 · 278 citations
    18. Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆ Annals of Oncology · 2020 · 86 citations
    19. Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis Pediatric blood & cancer · 2015 · 26 citations
    20. Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital Anais Brasileiros de Dermatologia · 2021 · 7 citations
    21. Transcriptome-guided development of a fibrosis-reversal compound reduces skin scarring and allows regeneration via mitochondrial uncoupling Cell Reports Medicine · 2026